Wegovy and Zepbound get primetime treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Politics
Supreme Court questions restricting government efforts to limit Covid-19 misinformation
WASHINGTON — Most of the Supreme Court’s justices on Monday seemed to question states’ arguments that…
Contineum Therapeutics files for IPO
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What happens when an approved drug doesn’t work?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Inside a push to create an NIH office for post-infection chronic illness
When the White House released President Biden’s 2025 budget requests this week, funding for biomedical…
Senators press HHS secretary on Change HealthCare cyberattack fallout
WASHINGTON— Senators want answers from the Biden administration on the recent cyberattack that froze millions…
STAT+: EPA restricts cancer-causing chemical used to sterilize medical devices
On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide…
Is CAR-T safe for early-stage patients?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: BIO severs ties with WuXi in the face of U.S. government concerns over China
WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese…
Geron’s resurgence might have been short-lived
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Good health care price transparency rules are at risk if Congress doesn’t act
Consider shopping for cereal in the grocery store. Buyers easily know how many grams of…
STAT+: Here’s what you might have missed in Biden’s budget proposal
WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his…
When did Wall Street sour on Lilly’s Alzheimer’s drug?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biden calls for election wake-up call on abortion rights — but new upheavals are fast approaching
WASHINGTON — President Biden started his sprawling national address Thursday night with a warning to…
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
WASHINGTON — Often, a president’s State of the Union address is a staid affair, with…
STAT+: Pharma giants, government spar in court over Medicare drug price negotiation
TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson and Johnson, Novartis, and…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
Where’s Lilly’s Alzheimer’s approval?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers
WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program…
Serum Institute of India wants government HPV contract
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Congress gives doctors Medicare pay bump, sets up December fight in new funding package
WASHINGTON — Doctors will get a 1.68% pay hike in Medicare starting March 9 under…
STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case…
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices
Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services….
STAT+: What does America’s crackdown on Chinese firms mean for the U.S. biotech sector?
WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
Biden ‘continues to be fit for duty,’ his doctor says, after president undergoes annual physical
BETHESDA, Md. — President Joe Biden “continues to be fit for duty,” his doctor wrote Wednesday…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Why won’t Medicare deliver food to sick seniors, if it could get them healthy?
WASHINGTON – Some twelve percent of traditional Medicare beneficiaries have heart failure. Roughly a quarter…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Congress ditches site-neutral hospital pay policy
WASHINGTON — Congress will not move forward with a controversial policy to equalize certain Medicare…
.jpg)
STAT+: Congress punts on PBM reform efforts
WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an…
The FDA isn’t afraid to yank a disappointing drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription…
STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA
WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Presidential age debate obscures a simple fact: Some cognitive skills improve as we get older
When a psychology professor in Michigan looked through his data on interpersonal conflict a decade…
STAT+: Obamacare plans don’t have to cover weight loss drugs. The government is considering changing that
WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new…
STAT+: Banning surprise medical bills is raising costs elsewhere
Without question, the new federal law banning surprise billing is achieving its goal of protecting…
Key congressman blasts HHS for lack of cooperation on Covid-19
The Health and Human Services Department’s lack of cooperation with a congressional committee investigating the…
STAT+: Medicare Advantage enrollment races past 33 million
Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a…
STAT+: Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech
CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised…
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: I’ve reported on the health of every president since Reagan. Here’s what I think about Trump and Biden
When I interviewed Ronald Reagan about his health in 1980, he was 69 and poised…
Covid-19 vaccine confidence soured by officials’ messaging, Republicans argue
WASHINGTON — A House hearing on vaccine safety claims sought to pierce through Americans’ falling…
Long Covid research funding at NIH gets a nearly 50% boost
WASHINGTON — The Biden administration has dedicated an additional $515 million to a major initiative…
STAT+: FTC to probe the role of middlemen in worsening drug shortage crisis
The Federal Trade Commission is launching a probe into the extent to which group purchasing…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…